Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client…
Browsing: Clinical Trials
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today awarded…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased…
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to…
Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration…
Announcement reinforces Moderna’s commitment to Asia and vision as a global commercial enterprise New subsidiaries to be established in Malaysia,…
Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global…
Apollomics Inc. an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced…
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced…
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced…
Initial fund targets medical devices, digital solutions, and diagnostics Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has…
Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled “Getting…